A groundbreaking study analysing tumours from 500 domestic cats has revealed striking genetic similarities with human cancers, potentially accelerating the development of targeted therapies for both species.
Shared Environment, Shared Disease
Domestic cats living in our homes are exposed to the same environmental hazards as humans – secondhand smoke, household chemicals, and urban pollutants. This makes them invaluable models for understanding how cancer develops in real-world conditions, according to researchers.
Dr Geoffrey Wood, a pathobiology professor at the University of Guelph in Canada and co-senior author of the study, explained: “Cats and humans share the same environment, so studying cancer in cats gives us unique insights into environmental factors that may influence tumour development in people.”
Genetic Breakthrough in Feline Tumours
The research team genetically analysed tumours from 500 cats – the largest study of its kind – to identify key “driver genes” responsible for uncontrolled cell growth. Their findings, published in the journal Science, uncovered significant genetic overlaps with human cancers.
The most compelling parallel emerged in aggressive breast cancer cases. More than 50% of feline breast tumours carried mutations in the FBXW7 gene – the same genetic damage linked to poorer outcomes in human breast cancer patients. When this gene malfunctions, it allows growth-promoting proteins to accumulate unchecked in healthy tissue.
Beyond breast cancer, researchers discovered shared genetic mutations across multiple cancer types, including those affecting the blood, bones, lungs, skin, gastrointestinal system, and brain.
From Laboratory to Clinical Trials
Laboratory testing revealed that tumours carrying the mutated FBXW7 gene showed heightened vulnerability to specific targeted chemotherapy drugs. While current tests have only been conducted on tissue samples, the findings could fast-track precision drug development for human treatments.
“This study can help us understand more about why cancer develops in cats and humans, how the world around us influences cancer risk, and possibly find new ways to prevent and treat it,” said Dr Wood.
The research aligns with the growing ‘One Medicine’ movement, which advocates for integrated human and veterinary health research. Historically, feline cancer genetics remained poorly understood, leaving scientists with limited data compared to human or canine tumour studies.
Open Access Database Benefits Global Research
In a move that will accelerate further discoveries, researchers have made the complete genetic database freely available to cancer institutes worldwide. This open-access approach ensures that laboratories across the globe can build upon these findings.
Dr Louise Van Der Weyden, senior author at the Wellcome Sanger Institute, noted: “We can now begin to take the next steps forward towards precision feline oncology to catch up with the diagnostic and therapeutic options that are available for dogs with cancer, and ultimately one day, humans.”
The study establishes a foundation that will benefit both animal and human medicine, potentially leading to earlier detection methods and more effective treatments tailored to individual genetic profiles rather than broad-spectrum approaches.
Why it Matters
This research represents a significant leap forward in precision oncology, demonstrating how studying diseases in animals can directly benefit human health. By identifying shared genetic triggers between cats and humans, scientists are not only improving our understanding of cancer development but also creating new pathways for developing targeted treatments. The open-access genetic database ensures that these discoveries can benefit patients worldwide, while the ‘One Medicine’ approach validates the importance of collaborative research across species boundaries. For pet owners and cancer patients alike, these findings offer hope that understanding disease in our animal companions may one day lead to better outcomes for humans.
